Department of Pneumology, University Hospital Ruhrlandklinik, Essen, Germany.
Respiration. 2012;83(2):115-24. doi: 10.1159/000324449. Epub 2011 Apr 7.
Conventional pulmonary rehabilitation programs improve exercise tolerance but have no effect on pulmonary function in patients with chronic obstructive pulmonary disease (COPD). The role of controlled breathing using respiratory biofeedback during rehabilitation of patients with COPD remains unclear.
To compare the effects of a conventional 4-week pulmonary rehabilitation program with those of rehabilitation plus controlled breathing interventions.
A randomized controlled trial was performed. Pulmonary function (FEV1), exercise capacity (6-min walking distance, 6 MWD), health-related quality of life (chronic respiratory questionnaire, CRQ) and cardiac autonomic function (rMSSD) were evaluated.
Forty COPD patients (mean±SD age 66.1±6.4, FEV1 45.9±17.4% predicted) were randomized to rehabilitation (n=20) or rehabilitation plus controlled breathing (n=20). There were no statistically significant differences between the two groups regarding the change in FEV1 (mean difference -0.8% predicted, 95% CI -4.4 to 2.9% predicted, p=0.33), 6 MWD (mean difference 12.2 m, 95% CI -37.4 to 12.2 m, p=0.16), CRQ (mean difference in total score 0.2, 95% CI -0.1 to 0.4, p=0.11) and rMSSD (mean difference 2.2 ms, 95% CI -20.8 to 25.1 ms, p=0.51).
In patients with COPD undergoing a pulmonary rehabilitation program, controlled breathing using respiratory biofeedback has no effect on exercise capacity, pulmonary function, quality of life or cardiac autonomic function.
常规的肺康复计划可以提高运动耐量,但对慢性阻塞性肺疾病(COPD)患者的肺功能没有影响。在 COPD 患者康复过程中使用呼吸生物反馈进行控制性呼吸的作用尚不清楚。
比较常规 4 周肺康复计划与康复加控制性呼吸干预的效果。
进行了一项随机对照试验。评估了肺功能(FEV1)、运动能力(6 分钟步行距离,6MWD)、健康相关生活质量(慢性呼吸系统问卷,CRQ)和心脏自主神经功能(rMSSD)。
40 名 COPD 患者(平均年龄±标准差 66.1±6.4 岁,FEV1 预测值的 45.9±17.4%)被随机分为康复组(n=20)或康复加控制性呼吸组(n=20)。两组间 FEV1 的变化(平均差异-0.8%预测值,95%CI-4.4 至 2.9%预测值,p=0.33)、6MWD(平均差异 12.2m,95%CI-37.4 至 12.2m,p=0.16)、CRQ(总分平均差异 0.2,95%CI-0.1 至 0.4,p=0.11)和 rMSSD(平均差异 2.2ms,95%CI-20.8 至 25.1ms,p=0.51)均无统计学差异。
在接受肺康复计划的 COPD 患者中,使用呼吸生物反馈进行控制性呼吸对运动能力、肺功能、生活质量或心脏自主神经功能没有影响。